Mephedrone interactions with cocaine: prior exposure to the 'bath salt' constituent enhances cocaine-induced locomotor activation in rats - PubMed (original) (raw)
Mephedrone interactions with cocaine: prior exposure to the 'bath salt' constituent enhances cocaine-induced locomotor activation in rats
Ryan A Gregg et al. Behav Pharmacol. 2013 Dec.
Abstract
Concurrent use of mephedrone (4-methylmethcathinone; MEPH) and established drugs of abuse is now commonplace, but knowledge about interactions between these drugs is sparse. The present study was designed to test the hypothesis that prior MEPH exposure enhances the locomotor-stimulant effects of cocaine and methamphetamine (METH). For cocaine experiments, rats pretreated with saline, cocaine (15 mg/kg), or MEPH (15 mg/kg) for 5 days were injected with cocaine after 10 days of drug absence. For METH experiments, rats pretreated with saline, METH (2 mg/kg), or MEPH (15 mg/kg) were injected with METH after 10 days of drug absence. Cocaine challenge produced greater locomotor activity after pretreatment with cocaine or MEPH than after pretreatment with saline. METH challenge produced greater locomotor activity after METH pretreatment than after saline pretreatment; however, locomotor activity in rats pretreated with MEPH or saline and then challenged with METH was not significantly different. The locomotor response to MEPH (15 mg/kg) was not significantly affected by pretreatment with cocaine (15 mg/kg) or METH (0.5, 2 mg/kg). The present demonstration that cocaine-induced locomotor activation is enhanced by prior MEPH exposure suggests that MEPH cross-sensitizes to cocaine and increases cocaine efficacy. Interestingly, MEPH cross-sensitization was not bidirectional and did not extend to METH, suggesting that the phenomenon is sensitive to specific psychostimulants.
Conflict of interest statement
Conflicts of Interest: None declared
Figures
Fig. 1. Effects of MEPH and cocaine exposure on locomotor activity
1A) Rats pretreated with saline (SAL), cocaine (COC) (15 mg/kg) or MEPH (15 mg/kg) were challenged with COC (15 mg/kg). 1B) Rats pretreated with saline or COC (15 mg/kg) were challenged with MEPH (15 mg/kg). Temporal data are expressed as activity counts + S.E.M. following COC (1A) or MEPH (1B) injection (arrow). Cumulative data (box) are expressed as total activity counts following COC (0–30 min) or MEPH (0–90) injection. N=8 rats/group. ***p < 0.001, **p < 0.01 or *p < 0.05 compared to SAL/COC; +p < 0.05 compared to COC/COC.
Fig. 2. Effects of MEPH and METH exposure on locomotor activity
2A) Rats pretreated with saline (SAL), METH (2 mg/kg) or MEPH (15 mg/kg) were challenged with METH (2 mg/kg). 2B) Rats pretreated with saline or METH (0.5, 2 mg/kg) were challenged with MEPH (15 mg/kg). Temporal data are expressed as activity counts + S.E.M. following METH (2A) or MEPH (2B) injection (arrow). Cumulative data (box) are expressed as total activity counts following METH (0–90 min) or MEPH (0–90) injection. N=8 rats/group. ***p < 0.001, **p < 0.01 or *p < 0.05 compared to SAL/METH; +++p < 0.001 compared to METH/METH.
Similar articles
- Combined effects of mephedrone and cocaine on locomotor activity and conditioned place preference in male Sprague-Dawley rats.
Kohler RJ, Cibelli J, Baker LE. Kohler RJ, et al. Behav Pharmacol. 2020 Jun;31(4):368-377. doi: 10.1097/FBP.0000000000000539. Behav Pharmacol. 2020. PMID: 32032101 Free PMC article. - Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.
Cameron KN, Kolanos R, Solis E Jr, Glennon RA, De Felice LJ. Cameron KN, et al. Br J Pharmacol. 2013 Apr;168(7):1750-7. doi: 10.1111/bph.12061. Br J Pharmacol. 2013. PMID: 23170765 Free PMC article. - Synthetic cathinones and stereochemistry: S enantiomer of mephedrone reduces anxiety- and depressant-like effects in cocaine- or MDPV-abstinent rats.
Philogene-Khalid HL, Hicks C, Reitz AB, Liu-Chen LY, Rawls SM. Philogene-Khalid HL, et al. Drug Alcohol Depend. 2017 Sep 1;178:119-125. doi: 10.1016/j.drugalcdep.2017.04.024. Epub 2017 Jun 13. Drug Alcohol Depend. 2017. PMID: 28646714 Free PMC article. - Mephedrone (4-methylmethcathinone), a principal constituent of psychoactive bath salts, produces behavioral sensitization in rats.
Gregg RA, Tallarida CS, Reitz A, McCurdy C, Rawls SM. Gregg RA, et al. Drug Alcohol Depend. 2013 Dec 1;133(2):746-50. doi: 10.1016/j.drugalcdep.2013.06.014. Epub 2013 Jul 23. Drug Alcohol Depend. 2013. PMID: 23890492 Free PMC article. - Stereochemistry and neuropharmacology of a 'bath salt' cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebrates.
Vouga A, Gregg RA, Haidery M, Ramnath A, Al-Hassani HK, Tallarida CS, Grizzanti D, Raffa RB, Smith GR, Reitz AB, Rawls SM. Vouga A, et al. Neuropharmacology. 2015 Apr;91:109-16. doi: 10.1016/j.neuropharm.2014.11.010. Epub 2014 Dec 9. Neuropharmacology. 2015. PMID: 25496724 Free PMC article.
Cited by
- Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator.
Gregg RA, Hicks C, Nayak SU, Tallarida CS, Nucero P, Smith GR, Reitz AB, Rawls SM. Gregg RA, et al. Neuropharmacology. 2016 Sep;108:111-9. doi: 10.1016/j.neuropharm.2016.04.014. Epub 2016 Apr 13. Neuropharmacology. 2016. PMID: 27085607 Free PMC article. - Sensitization to the locomotor stimulant effects of "bath salt" constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats.
Berquist MD 2nd, Traxler HK, Mahler AM, Baker LE. Berquist MD 2nd, et al. Drug Alcohol Depend. 2016 Jul 1;164:128-134. doi: 10.1016/j.drugalcdep.2016.05.001. Epub 2016 May 9. Drug Alcohol Depend. 2016. PMID: 27181413 Free PMC article. - Dopaminergic Effects of Major Bath Salt Constituents 3,4-Methylenedioxypyrovalerone (MDPV), Mephedrone, and Methylone Are Enhanced Following Co-exposure.
Allen SA, Tran LH, Oakes HV, Brown RW, Pond BB. Allen SA, et al. Neurotox Res. 2019 Jul;36(1):132-143. doi: 10.1007/s12640-019-00020-2. Epub 2019 Mar 16. Neurotox Res. 2019. PMID: 30879275 - Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture.
Harvey EL, Baker LE. Harvey EL, et al. Psychopharmacology (Berl). 2016 Feb;233(4):673-80. doi: 10.1007/s00213-015-4142-4. Epub 2015 Nov 12. Psychopharmacology (Berl). 2016. PMID: 26558618 Free PMC article. - Effects of 3,4-methylenedioxypyrovalerone (MDPV) pre-exposure on the aversive effects of MDPV, cocaine and lithium chloride: Implications for abuse vulnerability.
Woloshchuk CJ, Nelson KH, Rice KC, Riley AL. Woloshchuk CJ, et al. Drug Alcohol Depend. 2016 Oct 1;167:121-7. doi: 10.1016/j.drugalcdep.2016.08.008. Epub 2016 Aug 7. Drug Alcohol Depend. 2016. PMID: 27520883 Free PMC article.
References
- Achat-Mendes C, Anderson KL, Itzhak Y. Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood. Neuropharmacology. 2003;45:106–115. - PubMed
- Brandon CL, Marinelli M, Baker LK, White FJ. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology. 2001;25:651–661. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R15 DA025314/DA/NIDA NIH HHS/United States
- DA032718/DA/NIDA NIH HHS/United States
- DA025314/DA/NIDA NIH HHS/United States
- DA01342/DA/NIDA NIH HHS/United States
- P30 DA013429/DA/NIDA NIH HHS/United States
- R21 DA032718/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical